Abstract

Testosterone deficiency causes fat deposition, particularly in visceral fat, and its replacement might reverse fat accumulation, however, the underlying mechanisms of such processes under diet-induced adiposity are largely unknown. To gain insights into the genome-wide role of androgen on visceral adipose tissue (VAT), RNA-Seq was used to investigate testosterone deficiency induced changes of VAT in miniature pigs fed a high-fat and high-cholesterol (HFC) diet among intact male pigs (IM), castrated male pigs (CM), and castrated male pigs with testosterone replacement (CMT) treatments. The results showed that testosterone deficiency significantly increased VAT deposition and serum leptin concentrations. Moreover, a total of 1732 differentially expressed genes (DEGs) were identified between any two groups. Compared with gene expression profiles in IM and CMT pigs, upregulated genes in CM pigs, i.e., LOC100520753 (CD68), LCN2, EMR1, S100A9, NCF1 (p47phox), and LEP, were mainly involved in inflammatory response, oxidation-reduction process, and lipid metabolic process, while downregulated genes in CM pigs, i.e., ABHD5, SPP1, and GAS6, were focused on cell differentiation and cell adhesion. Taken together, our study demonstrates that testosterone deficiency alters the expression of numerous genes involved in key biological processes of VAT accumulation under HFC diet and provides a novel genome-wide view on the role of androgen on VAT deposition under HFC diet, thus improving our understanding of the molecular mechanisms involved in VAT changes induced by testosterone deficiency.

Highlights

  • Visceral adiposity represents excess visceral fat tissue (VAT) deposition in body, which is associated with several critical human diseases such as type 2 diabetes, metabolic syndrome and cardiovascular disease, suggesting visceral adiposity is a high disease risk factor in the life

  • Testosterone treatment reduced waist circumference, waist/hip ratio, visceral fat mass and metabolic syndrome mainly caused by visceral adiposity in obese hypogonadal men [8,9], strongly suggesting that testosterone replacement might be used for visceral adiposity treatment in men caused by testosterone deficiency

  • Castration significantly enhanced VAT fat, while testosterone treatment significantly decreased VAT fat, with no significant difference between intact male pigs (IM) and castrated male pigs with testosterone replacement (CMT) pig groups (Figure 1A)

Read more

Summary

Introduction

Visceral adiposity represents excess visceral fat tissue (VAT) deposition in body, which is associated with several critical human diseases such as type 2 diabetes, metabolic syndrome and cardiovascular disease, suggesting visceral adiposity is a high disease risk factor in the life. Low testosterone levels result in excess VAT accumulation or waist circumference in men, increasing visceral adiposity [3,4,5], indicating that diet and sex hormone could play important roles on visceral adiposity. Testosterone replacement decreased visceral fat weight and size in rabbits with high-fat (HFD) diet [11] and visceral fat size in hypogonadal and aged male rats [12]. These data clearly show that testosterone replacement might be considered as a safe and effective therapy for obesity in men or animals with testosterone deficiency [13]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call